Rocket Lab's Strategic Momentum: Defense Contracts and Financial Milestones

Rocket Lab reports record 2025 revenue of $602M, a $1.85B backlog, and key milestones for its Neutron rocket and hypersonic HASTE program, despite recent stock pressure.

Recent operational and financial updates from Rocket Lab USA underscore its accelerating role in the defense and space sectors. A series of successful tests, new launch agreements, and record annual figures paint a picture of a company with significant forward momentum.

Financial Performance and Forward Guidance

The company's latest financial results reveal substantial growth. For the full year 2025, Rocket Lab reported record revenue of $602 million, representing a 38% increase over the prior year. The fourth quarter alone set a new high with $180 million in sales.

Looking ahead, management has provided specific guidance for the first quarter of 2026, anticipating revenue in the range of $185 million to $200 million. Furthermore, the total backlog reached $1.85 billion by the end of 2025, marking a striking 73% year-over-year expansion. A key development milestone was also confirmed: the medium-lift Neutron rocket is now targeting its inaugural flight for the fourth quarter of 2026.

Expanding Defense and Commercial Launch Manifest

The company's operational achievements are building on multiple fronts. On February 26, Rocket Lab announced a new, multi-launch agreement with BlackSky. This contract covers four dedicated Electron rocket missions, extending an existing partnership. The total number of planned launches for BlackSky now stands at 17.

This commercial activity is paralleled by a deepening engagement in defense contracting. Rocket Lab's active contracts related to satellite constellations now represent an aggregate value of $816 million. A central component of this work is its role as the Lead Integrator for the U.S. Space Development Agency (SDA).

Hypersonic Test Success

A significant technical demonstration occurred on February 27 with the launch of Rocket Lab's HASTE rocket from the Mid-Atlantic Regional Spaceport on Wallops Island, Virginia. The mission, named "That’s Not A Knife," was conducted for the Defense Innovation Unit (DIU) in support of a U.S. initiative to advance hypersonic technology.

For the company, this launch held particular operational significance. It was the seventh overall HASTE mission and the third such mission in 2026. It also marked the 82nd mission in the company's history. Crucially, it represented the second successful hypersonic test mission for the DIU completed within a three-month period.

Market Context and Upcoming Catalysts

Despite these positive developments, investor sentiment has recently been mixed. Shares closed at $69.10 on Friday, declining by 4.89%. On a 30-day basis, the stock is down approximately 22%.

The immediate focus for markets is now less on a specific share price level and more on the company's execution against its stated near-term goals. Key catalysts will be whether Rocket Lab delivers on its Q1 revenue guidance of $185 to $200 million and maintains the development timeline for the Neutron rocket, keeping its first launch on track for Q4 2026.